Loading
AB
Ambrx Biopharma Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 19 Sept 2023.
Ambrx Biopharma Inc.: what insiders have been doing
Every trade that managers of Ambrx Biopharma Inc. disclose to SEC (Form 4) is tracked on this page. Ambrx Biopharma Inc. has had no insider filing for more than a year; the last one goes back to 19 September 2023.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
12
Thresholds
n/a
Buy Volume
€65M
5 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
RevenueUS$6.4M
Net income-US$67.5M-1053.7% margin
Last declaration on 19 September 2023
Declarations12 total
751,233 shares@ US$9.24479.9% of flowOrdinary SharesSEC:0000929638-23-002564:1
Canonical exit: 17 Dec 2023 (T+90)
1,401,505 shares@ US$9.047918.3% of flowOrdinary SharesSEC:0000929638-23-002564:0
Canonical exit: 14 Dec 2023 (T+90)
125,000 shares0Ordinary SharesSEC:0000950170-23-046801:0
85,000 shares0Ordinary SharesSEC:0000899243-23-015154:0
85,000 shares0Ordinary SharesSEC:0000899243-23-015152:0
85,000 shares0Ordinary SharesSEC:0000899243-23-015148:0
85,000 shares0Ordinary SharesSEC:0000899243-23-015185:0
1,000,000 shares0Ordinary SharesSEC:0001209191-23-026101:0
2,750,000 shares0Ordinary SharesSEC:0001209191-23-026093:0
3,376,646 shares@ US$11.269553.1% of flowOrdinary SharesSEC:0000929638-23-001211:0
Canonical exit: 17 Jul 2023 (T+90)
1,193,808 shares@ US$9.160215.1% of flowOrdinary SharesSEC:0000929638-23-001185:0
Canonical exit: 12 Jul 2023 (T+90)
250,000 shares@ US$9.95313.6% of flowOrdinary SharesSEC:0000929638-23-000867:0
Canonical exit: 12 Jun 2023 (T+90)
12 of 12 declarations
About Ambrx Biopharma Inc.
Ambrx Biopharma Inc. is a biopharmaceutical company focused on developing therapies based on recombinant proteins. It utilizes innovative technology to design drugs targeting serious diseases.
